Today’s top gainers include the company Eli Lilly and Company (NYSE:LLY) which is in the industry Drug Manufacturers – Major, gaining -1.01% today. In the last week its performance is -0.61%, and 10.23% for the past quarter. Currently, Eli Lilly and Company, LLY has a target price of 96.81, so today’s gain of -1.01% is a significant step towards its target price. The GAP today is therefore -0.34%.
Eli Lilly and Company (NYSE:LLY), has a market cap of 91076.57, and is based in USA. Insider ownership is at 11.60%, and institutional ownership is 76.70%.
At the current price of 81.59, it has a dividend yield of 2.48%, and its target price is 96.81. This is with a profit margin of 12.00%, and total debt/equity of 0.64. Eli Lilly and Company (NYSE:LLY) has a P/E of 35.45, as well as a forward P/E of 20.17.
With a current EPS of 2.33, and a forecasted EPS growth for next year at 14.04%,Eli Lilly and Company (NYSE:LLY) has had a EPS growth for the past five years at -13.20%. For the next five years EPS growth is projected to be 12.95%.
Performance for the year is -0.17%. Since its IPO date on 6/1/1972, the total performance to date is -0.84%.
Volume today for Eli Lilly and Company (NYSE:LLY), is 2755267, while its average volume is 4138.89. Whilst the total gain today was -1.01%, it did have a day high of -2.63%.
Volatility for this week has been at 1.09%, and 1.25% for the month. The 52-week low for Eli Lilly and Company, LLY has been 21.00%, while the 52-week-high has reached -10.36%.
Looking at its return of investments, which is 9.50%, and its return on assets is 6.90%. Eli Lilly and Company (NYSE:LLY) has an operating margin of 14.60%. With a sales growth of 8.60% quarter over quarter. Bearing in mind that Eli Lilly and Company, LLY is in the sector Healthcare, its long-term debt/equity is 0.59, and has a current ratio of 1.5 and 1.1 for quick ratio.
So what is the value of Eli Lilly and Company? Well its PEG is 2.74, and the P/S is 4.42, along with a P/B of 5.96. Meanwhile it has a p/cash of 23.15.